TDLU Involution and Breast Cancer Risk-Reply

Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):798. doi: 10.1158/1055-9965.EPI-20-1748.

¹ Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts. yheng@bidmc.harvard.edu.
² Division of Population Sciences, Dana Farber Cancer Institute, Boston, Massachusetts.
³ Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
⁴ Department of Pathology, Harvard Medical School and Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.
⁵ Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.

No abstract available

Publication types